Results 181 to 190 of about 32,062 (289)

Cryoprecipitate utilisation, shortages and institutional policies in the United States: A survey of practices and policies

open access: yesTransfusion Medicine, EarlyView.
Abstract Background Since the COVID‐19 pandemic, demand for blood products has remained high, while donations have declined. Institutional policies guiding the use of these products may affect their availability, utilisation and waste. We surveyed blood banks (BBs) in the United States (U.S.) to assess policies and practices related to cryoprecipitate ...
Chinelo P. Onyenekwu   +3 more
wiley   +1 more source

Determinants of Immune Tolerance Induction Outcomes in 237 Persons With Severe Hemophilia A

open access: yesEuropean Journal of Haematology, Volume 117, Issue 5, Page 1292-1300, November 2026.
ABSTRACT Immune tolerance induction (ITI) to eradicate an immune response against factor VIII (FVIII) has been used in hemophilia A (HA) with various success rates, costs, and treatment burden. The present study aimed to identify markers predictive of ITI success.
Marcus Fager Ferrari   +5 more
wiley   +1 more source

Strengthening Clinical Nurses' Research Capacity: A Scoping Review of Factors That Influence Nurses' Engagement in Clinical Research

open access: yesJournal of Clinical Nursing, Volume 35, Issue 11, Page 4582-4628, November 2026.
ABSTRACT Aim To identify and map evidence on factors that influence nurses' engagement in clinical research. Design A scoping review was conducted in accordance with the JBI methodology. Methods First, titles and abstracts of articles, then full‐text articles, were screened by two independent researchers against inclusion and exclusion criteria.
Lyndsay Jerusha Mackay   +9 more
wiley   +1 more source

Treatment of Deep Vein Thrombosis in Congenital Factor VII Deficiency: A Case Report and Literature Review

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Managing thrombosis in patients with bleeding disorders requires careful assessment of thromboembolic and bleeding risks, tailoring antithrombotic treatment in terms of type, dose, and duration, and considering the need for replacement therapy based on individual factor levels and bleeding history.
Synnøve Gjelsten Mortensen   +4 more
wiley   +1 more source

Optimizing Perioperative Management of Haemophilia B With rFIX-FP: Pharmacokinetic Validation of the Hemoptidose Tool. [PDF]

open access: yesHaemophilia
Delavenne X   +10 more
europepmc   +1 more source

Long Term Follow Up of Hereditary Thrombotic Thrombocytopenic Purpura on Plasma Therapy for 9 Years: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT A 7.6‐year‐old boy with hTTP had fever‐induced hemorrhagic rash, MAHA, cerebral infarction, and renal impairment. After plasma therapy, symptoms were partially relieved; 9‐year follow‐up showed regular plasma transfusion was needed, with CKD Stage 3.
Dai Xiaomei   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy